Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News TearLab Corp - Ordinary Shares TEAR

Healthcare Diagnostics & Research
TearLab Corp is a part of the diagnostic industry. It is an in-vitro diagnostic company based in the United States. TearLab has commercialized a proprietary tear testing platform, the TearLab Osmolarity System that enables eye care practitioners to test for highly sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The company operates through its wholly-owned... see more

Recent & Breaking News (GREY:TEAR)

TearLab Announces Acquisition By Accelmed Partners And Related $25 Million Investment

PR Newswire May 11, 2020

TearLab Corporation Confirms Merger Discussions

GlobeNewswire May 7, 2020

TearLab Resubmits 510(k) for U.S. FDA Clearance of the TearLab Discovery(TM) MMP-9 Test

GlobeNewswire April 22, 2020

TearLab Corporation Reports Fourth Quarter and Full Year 2019 Financial Results

GlobeNewswire March 5, 2020

TearLab Corporation Reports Third Quarter 2019 Financial Results

GlobeNewswire November 7, 2019

TearLab Corporation Reports Second Quarter and First Half 2019 Financial Results

GlobeNewswire August 8, 2019

TearLab Corporation Reports First Quarter 2019 Financial Results

GlobeNewswire May 9, 2019

TearLab Corporation Reports Fourth Quarter and Full Year 2018 Financial Results

GlobeNewswire March 21, 2019

TearLab Corporation Reports Third Quarter 2018 Financial Results

GlobeNewswire November 7, 2018

TearLab Update on 510(k) for U.S. FDA Clearance of Discovery™ MMP-9 Test

GlobeNewswire October 10, 2018

TearLab Corporation Reports Second Quarter and First Half 2018 Financial Results

GlobeNewswire August 9, 2018

TearLab Corporation Reports First Quarter 2018 Financial Results

GlobeNewswire May 10, 2018

TearLab Provides Update on 510(k) Filing for U.S. FDA Clearance of TearLab Discovery™ Platform

GlobeNewswire April 11, 2018

TearLab Corporation Announces Voluntary Delisting From Toronto Stock Exchange

GlobeNewswire March 16, 2018

TearLab Corporation Reports Fourth Quarter and Full Year 2017 Financial Results

GlobeNewswire March 2, 2018

TearLab Osmolarity System Launches in Brazil

GlobeNewswire February 28, 2018

TearLab Submits 510(k) for U.S. FDA Clearance of TearLab Discovery™ Platform

GlobeNewswire January 4, 2018

TearLab Prices $3.0 Million Registered Direct Offering

GlobeNewswire December 6, 2017

TearLab Launches Registered Direct Offering

GlobeNewswire November 30, 2017

TearLab Corporation Reports Third Quarter and September Year-To-Date 2017 Financial Results

GlobeNewswire November 13, 2017